Search research articles
Contact Us
Filters
Showing results (11-20 of 16) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 16 results.
The Journal of Antimicrobial Chemotherapy
|
September 5, 2013
Successful treatment of simulated Clostridium difficile infection in a human gut model by fidaxomicin first line and after vancomycin or metronidazole failure
C H Chilton, G S Crowther, J Freeman, et al.
Journal of Medical Microbiology
|
January 22, 2014
Comparative proteomic analysis of Clostridium difficile isolates of varying virulence
C H Chilton, S E Gharbia, M Fang, et al.
The Journal of Antimicrobial Chemotherapy
|
October 17, 2013
In vitro activity of cadazolid against clinically relevant Clostridium difficile isolates and in an in vitro gut model of C. difficile infection
C H Chilton, G S Crowther, S D Baines, et al.
The Journal of Antimicrobial Chemotherapy
|
February 6, 2015
In vitro susceptibility of Clostridium difficile to SMT19969 and comparators, as well as the killing kinetics and post-antibiotic effects of SMT19969 and comparators against C. difficile
D Corbett, A Wise, S Birchall, et al.
The Journal of Antimicrobial Chemotherapy
|
April 17, 2019
Dissemination of multiple carbapenem resistance genes in an in vitro gut model simulating the human colon
C M Rooney, A E Sheppard, E Clark, et al.
The Journal of Hospital Infection
|
May 1, 2021
The effect of intestinal microbiota dysbiosis on growth and detection of carbapenemase-producing Enterobacterales within an in vitro gut model
H C Harris, A M Buckley, W Spittal, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 16) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 16 results.
The Journal of Antimicrobial Chemotherapy
|
September 5, 2013
Successful treatment of simulated Clostridium difficile infection in a human gut model by fidaxomicin first line and after vancomycin or metronidazole failure
C H Chilton, G S Crowther, J Freeman, et al.
Journal of Medical Microbiology
|
January 22, 2014
Comparative proteomic analysis of Clostridium difficile isolates of varying virulence
C H Chilton, S E Gharbia, M Fang, et al.
The Journal of Antimicrobial Chemotherapy
|
October 17, 2013
In vitro activity of cadazolid against clinically relevant Clostridium difficile isolates and in an in vitro gut model of C. difficile infection
C H Chilton, G S Crowther, S D Baines, et al.
The Journal of Antimicrobial Chemotherapy
|
February 6, 2015
In vitro susceptibility of Clostridium difficile to SMT19969 and comparators, as well as the killing kinetics and post-antibiotic effects of SMT19969 and comparators against C. difficile
D Corbett, A Wise, S Birchall, et al.
The Journal of Antimicrobial Chemotherapy
|
April 17, 2019
Dissemination of multiple carbapenem resistance genes in an in vitro gut model simulating the human colon
C M Rooney, A E Sheppard, E Clark, et al.
The Journal of Hospital Infection
|
May 1, 2021
The effect of intestinal microbiota dysbiosis on growth and detection of carbapenemase-producing Enterobacterales within an in vitro gut model
H C Harris, A M Buckley, W Spittal, et al.
Page
of 2